Wenbin Kuang

559 total citations
27 papers, 403 citations indexed

About

Wenbin Kuang is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Wenbin Kuang has authored 27 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Cancer Research. Recurrent topics in Wenbin Kuang's work include Synthesis and biological activity (3 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Cancer therapeutics and mechanisms (3 papers). Wenbin Kuang is often cited by papers focused on Synthesis and biological activity (3 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Cancer therapeutics and mechanisms (3 papers). Wenbin Kuang collaborates with scholars based in China and United States. Wenbin Kuang's co-authors include Peng Yang, Xiao Wang, Ye Zhang, Zhen‐Feng Chen, Xiaoling Yang, Ri-Zhen Huang, Qiuchan Deng, Wensheng Li, Wenjian Min and Haolin Zhang and has published in prestigious journals such as Nature Communications, Journal of Materials Chemistry A and Journal of Medicinal Chemistry.

In The Last Decade

Wenbin Kuang

25 papers receiving 399 citations

Peers

Wenbin Kuang
Mauro Sergi Italy
Gaoran Xu China
Chunxia Huang China
Clement Penny South Africa
Yansong Dong China
Yang-Bing Li China
Yihong He China
Se‐Lim Kim South Korea
Mauro Sergi Italy
Wenbin Kuang
Citations per year, relative to Wenbin Kuang Wenbin Kuang (= 1×) peers Mauro Sergi

Countries citing papers authored by Wenbin Kuang

Since Specialization
Citations

This map shows the geographic impact of Wenbin Kuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbin Kuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbin Kuang more than expected).

Fields of papers citing papers by Wenbin Kuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenbin Kuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbin Kuang. The network helps show where Wenbin Kuang may publish in the future.

Co-authorship network of co-authors of Wenbin Kuang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenbin Kuang. A scholar is included among the top collaborators of Wenbin Kuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenbin Kuang. Wenbin Kuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jiaxing, Yiwen Zhang, Wenjian Min, et al.. (2024). ADAR1 is required for acute myeloid leukemia cell survival by modulating post-transcriptional Wnt signaling through impairing miRNA biogenesis. Leukemia. 39(3). 599–613. 5 indexed citations
2.
Wu, Haijun, et al.. (2024). Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients. Journal of Multidisciplinary Healthcare. Volume 17. 1127–1135. 9 indexed citations
3.
Kuang, Wenbin, et al.. (2023). Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers. European Journal of Medicinal Chemistry. 250. 115175–115175. 23 indexed citations
4.
Kuang, Wenbin, et al.. (2023). Inhibited Expression of NLRP12 Promotes the Development of Triple-Negative Breast Cancer by Activating the NF-κB Pathway. Cell Biochemistry and Biophysics. 81(4). 727–735. 6 indexed citations
5.
Wang, Xiao, et al.. (2023). Kaempferol improves acute kidney injury via inhibition of macrophage infiltration in septic mice. Bioscience Reports. 43(7). 10 indexed citations
6.
Hou, Yi, Fang Zhang, Wenjian Min, et al.. (2022). Discovery of Novel Phosphoinositide-3-Kinase α Inhibitors with High Selectivity, Excellent Bioavailability, and Long-Acting Efficacy for Gastric Cancer. Journal of Medicinal Chemistry. 65(14). 9873–9892. 12 indexed citations
7.
Kuang, Wenbin, Haolin Zhang, Xiao Wang, & Peng Yang. (2022). Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis. Acta Pharmaceutica Sinica B. 12(8). 3201–3214. 21 indexed citations
8.
Yuan, Kai, Wenbin Kuang, Xiao Wang, et al.. (2022). Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer. Nature Communications. 13(1). 2903–2903. 13 indexed citations
9.
Hao, Cheng, Tuan Liu, Wangcheng Liu, et al.. (2022). Recyclable CFRPs with extremely high Tg: hydrothermal recyclability in pure water and upcycling of the recyclates for new composite preparation. Journal of Materials Chemistry A. 10(29). 15623–15633. 51 indexed citations
10.
Shen, Hao, et al.. (2022). Pan-cancer analysis of DNA methyltransferase family with potential implications in prognosis and immunology in human cancer. Genes & Diseases. 10(4). 1206–1209. 1 indexed citations
11.
Yuan, Kai, Shengnan Xie, Zhixia Qiu, et al.. (2021). Discovery of Dual CDK6/PIM1 Inhibitors with a Novel Structure, High Potency, and Favorable Druggability for the Treatment of Acute Myeloid Leukemia. Journal of Medicinal Chemistry. 65(1). 857–875. 13 indexed citations
12.
Yuan, Kai, Wenbin Kuang, Wenjian Min, et al.. (2021). Discovery of novel and orally bioavailable CDK 4/6 inhibitors with high kinome selectivity, low toxicity and long-acting stability for the treatment of multiple myeloma. European Journal of Medicinal Chemistry. 228. 114024–114024. 10 indexed citations
13.
Hou, Yi, Wenbin Kuang, Wenjian Min, et al.. (2021). Design, Synthesis, and Biological Evaluation of Icaritin Derivatives as Novel Putative DEPTOR Inhibitors for Multiple Myeloma Treatment. Journal of Medicinal Chemistry. 64(20). 14942–14954. 9 indexed citations
14.
Kuang, Wenbin, et al.. (2021). Association of hemoglobin H (HbH) disease with hemoglobin A1c and glycated albumin in diabetic and non-diabetic patients. Clinical Chemistry and Laboratory Medicine (CCLM). 59(6). 1127–1132. 7 indexed citations
15.
Yuan, Kai, Wenjian Min, Xiao Wang, et al.. (2020). Discovery of Novel and Selective CDK4/6 Inhibitors By Pharmacophore and structure-based Virtual Screening. Future Medicinal Chemistry. 12(12). 1121–1136. 14 indexed citations
16.
Yang, Xiaoling, et al.. (2020). <p>The Novel Circular RNA Circ-PGAP3 Promotes the Proliferation and Invasion of Triple Negative Breast Cancer by Regulating the miR-330-3p/Myc Axis</p>. OncoTargets and Therapy. Volume 13. 10149–10159. 34 indexed citations
17.
Liang, Gui-Bin, et al.. (2020). Design, synthesis and biological evaluation of naphthalenebenzimidizole platinum (II) complexes as potential antitumor agents. European Journal of Medicinal Chemistry. 188. 112033–112033. 20 indexed citations
18.
Kuang, Wenbin, Ri-Zhen Huang, Jiao-Lan Qin, et al.. (2018). Design, synthesis and pharmacological evaluation of new 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one derivatives as potential antitumor agents. European Journal of Medicinal Chemistry. 157. 139–150. 25 indexed citations
19.
Lin, Yan, et al.. (2017). IL-12 induces autophagy in human breast cancer cells through AMPK and the PI3K/Akt pathway. Molecular Medicine Reports. 16(4). 4113–4118. 29 indexed citations
20.
Li, Pu, Ping Liu, Chenggui Liu, et al.. (2013). Development of a Chemiluminescence Immunoassay for Serum YB-1 and its Clinical Application as a Potential Diagnostic Marker for Hepatocellular Carcinoma. Hepatitis Monthly. 13(6). e8918–e8918. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mauro Sergi Breakdown of academic impact, for papers by Gaoran Xu Breakdown of academic impact, for papers by Chunxia Huang Breakdown of academic impact, for papers by Clement Penny Breakdown of academic impact, for papers by Yansong Dong Breakdown of academic impact, for papers by Yang-Bing Li Breakdown of academic impact, for papers by Yihong He Breakdown of academic impact, for papers by Se‐Lim Kim
Rankless by CCL
2026